home / stock / cycc / cycc news

CYCC News and Press, Cyclacel Pharmaceuticals Inc. From 03/06/24

Stock Information
Company Name: Cyclacel Pharmaceuticals Inc.
Stock Symbol: CYCC
Market: NASDAQ
Website: cyclacel.com
Menu
CYCC CYCC Quote CYCC Short CYCC News CYCC Articles CYCC Message Board
Get CYCC Alerts

News, Short Squeeze, Breakout and More Instantly...
CYCC - Cyclacel Pharmaceuticals receives $2.9M R&D tax credit

2024-03-06 09:41:52 ET More on Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals announces registered direct and private placement offering Seeking Alpha’s Quant Rating on Cyclacel Pharmaceuticals Historical earnings data for Cyclacel Pharmaceuticals F...
CYCC - Cyclacel Pharmaceuticals Announces Receipt of $2.9 Million R&D Tax Credit

BERKELEY HEIGHTS, N.J., March 06, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines based on cancer cell biology, announced that it received £2.3 million (approximate...

CYCC - Expected US Company Earnings on Monday, March 4th, 2024

Crescent Energy Company Class A (CRGY) is expected to report $0.21 for Q4 2023 ThredUp Inc. (TDUP) is expected to report $-0.13 for Q4 2023 Wright Investors` Service Holdings Inc (IWSH) is expected to report for Q4 2023 Bridgford Foods Corporation (BRID) is expected to report for Q1 2...

CYCC - Cyclacel Pharmaceuticals to Participate in 2024 BIO CEO & Investor Conference

BERKELEY HEIGHTS, N.J., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines based on cancer cell biology, today announced that Spiro Rombotis, President and Chief E...
CYCC - Cyclacel Pharmaceuticals stock slumps on termination of chief medical officer

2024-01-30 09:53:28 ET More on Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals, Inc. (CYCC) Q3 2023 Earnings Call Transcript Cyclacel Pharmaceuticals announces registered direct and private placement offering Seeking Alpha’s Quant Rating on Cyclacel Pharmace...

CYCC - Cyclacel Pharmaceuticals Announces the Appointment of Brian Schwartz, M.D. as Chief Medical Officer

BERKELEY HEIGHTS, N.J., Jan. 30, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines based on cancer cell biology, announced today that Brian Schwartz, M.D. will assume the ...

CYCC - Cyclacel Pharmaceuticals files to sell 411K shares of common stock

2024-01-19 17:05:04 ET More on Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals, Inc. (CYCC) Q3 2023 Earnings Call Transcript Cyclacel Pharmaceuticals announces registered direct and private placement offering Seeking Alpha’s Quant Rating on Cyclacel Pharmace...
CYCC - Cyclacel Pharmaceuticals, ClearPoint Neuro among healthcare movers

2024-01-09 10:00:06 ET More on Health Care Select Sector SPDR XLV Likely Back To Outperforming Covid-vaccine makers top laggard list, LLY and WST top gainers list Healthcare and utilities could perform better in 2024 - analyst For further details see: Cyc...

CYCC - CYCC, SGD and ACON among pre-market losers

2024-01-09 08:21:38 ET More on Pre-market losers $ stocks. Cyclacel Pharmaceuticals, Inc. (CYCC) Q3 2023 Earnings Call Transcript Cyclacel Pharmaceuticals announces registered direct and private placement offering Financial information for Aclarion, Inc. Seek...

CYCC - CYCC regains compliance with Nasdaq

2024-01-08 09:33:32 ET More on Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals, Inc. (CYCC) Q3 2023 Earnings Call Transcript Cyclacel Pharmaceuticals announces registered direct and private placement offering For further details see: CYCC regains compliance wit...
Previous 10 Next 10